Circulating progenitor cells are associated with plaque progression and long-term outcomes in heart transplant patients

• Abstract
• Supplementary data

Promise of autologous CD34+ stem/progenitor cell therapy for treatment of cardiovascular disease Get access

• Abstract

Mitochondrial targeted peptides preserve mitochondrial organization and decrease reversible myocardial changes in early swine metabolic syndrome

• Abstract
• Supplementary data

Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease Get access

• Abstract
• Supplementary data

Osteopontin: an emerging therapeutic target in uraemic vascular disease Get access

• Extract

Humanin is expressed in human vascular walls and has a cytoprotective effect against oxidized LDL-induced oxidative stress Get access

• Abstract

On to the road to degradation: atherosclerosis and the proteasome Get access

• Abstract

Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia Get access

• Abstract

The dynamic vasa vasorum Get access

• Abstract

Corrigendum to: “The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended” [Cardiovasc. Res. 61 (2004) 11–21]

• Extract

The ubiquitin–proteasome system in cardiovascular diseases—a hypothesis extended Get access

• Abstract

Hypertension exacerbates the effect of hypercholesterolemia on the myocardial microvasculature Get access

• Abstract

Dendroaspis natriuretic peptide relaxes isolated human arteries and veins Get access

• Abstract

Chronic antioxidant supplementation attenuates nuclear factor-κB activation and preserves endothelial function in hypercholesterolemic pigs Get access

• Abstract

Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia Get access

• Abstract

Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF_2α, in experimental hypercholesterolemia Get access

• Abstract

Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c Get access

• Abstract

Endothelins Get access